138 related articles for article (PubMed ID: 36779909)
21. TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children.
Qian M; Cao X; Devidas M; Yang W; Cheng C; Dai Y; Carroll A; Heerema NA; Zhang H; Moriyama T; Gastier-Foster JM; Xu H; Raetz E; Larsen E; Winick N; Bowman WP; Martin PL; Mardis ER; Fulton R; Zambetti G; Borowitz M; Wood B; Nichols KE; Carroll WL; Pui CH; Mullighan CG; Evans WE; Hunger SP; Relling MV; Loh ML; Yang JJ
J Clin Oncol; 2018 Feb; 36(6):591-599. PubMed ID: 29300620
[TBL] [Abstract][Full Text] [Related]
22. Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survival.
Salmoiraghi S; Montalvo ML; Ubiali G; Tosi M; Peruta B; Zanghi P; Oldani E; Boschini C; Kohlmann A; Bungaro S; Intermesoli T; Terruzzi E; Angelucci E; Cavattoni I; Ciceri F; Bassan R; Rambaldi A; Spinelli O
Haematologica; 2016 Jun; 101(6):e245-8. PubMed ID: 26992948
[No Abstract] [Full Text] [Related]
23. Evaluating approaches to enhance survival in children with hypodiploid acute lymphoblastic leukaemia (ALL).
Miller L; Kobayashi S; Pauly M; Lew G; Saxe D; Keller F; Qayed M; Castellino S
Br J Haematol; 2019 May; 185(3):613-616. PubMed ID: 30255927
[No Abstract] [Full Text] [Related]
24. Role of p53 in regulation of hematopoiesis in health and disease.
Barajas S; Cai W; Liu Y
Curr Opin Hematol; 2022 Jul; 29(4):194-200. PubMed ID: 35787548
[TBL] [Abstract][Full Text] [Related]
25. Impact of
Firtina S; Erbilgin Y; Hatirnaz Ng O; Karaman S; Karakas Z; Celkan TT; Gelen SA; Yildirmak Y; Ozbek U; Sayitoglu M
Scand J Clin Lab Invest; 2023 May; 83(3):187-193. PubMed ID: 37029683
[TBL] [Abstract][Full Text] [Related]
26. Analysis of TP53 mutations in relapsed childhood acute lymphoblastic leukemia.
Gump J; McGavran L; Wei Q; Hunger SP
J Pediatr Hematol Oncol; 2001 Oct; 23(7):416-9. PubMed ID: 11878574
[TBL] [Abstract][Full Text] [Related]
27. Mutation of the TP53 gene in acute lymphoblastic leukemia does not affect survival outcomes after haploidentical hematopoietic stem cell transplantation.
Zhou C; Zheng F; Xu L; Zhang X; Chang Y; Mo X; Sun Y; Huang X; Wang Y
Int J Cancer; 2023 Mar; 152(5):977-985. PubMed ID: 36251447
[TBL] [Abstract][Full Text] [Related]
28. TP53 codon 72 polymorphism and risk of acute leukemia.
Dunna NR; Vure S; Sailaja K; Surekha D; Raghunadharao D; Rajappa S; Vishnupriya S
Asian Pac J Cancer Prev; 2012; 13(1):347-50. PubMed ID: 22502699
[TBL] [Abstract][Full Text] [Related]
29. Single nucleotide polymorphism array-based signature of low hypodiploidy in acute lymphoblastic leukemia.
Creasey T; Enshaei A; Nebral K; Schwab C; Watts K; Cuthbert G; Vora A; Moppett J; Harrison CJ; Fielding AK; Haas OA; Moorman AV
Genes Chromosomes Cancer; 2021 Sep; 60(9):604-615. PubMed ID: 33938069
[TBL] [Abstract][Full Text] [Related]
30. Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients.
Chen C; Bartenhagen C; Gombert M; Okpanyi V; Binder V; Röttgers S; Bradtke J; Teigler-Schlegel A; Harbott J; Ginzel S; Thiele R; Husemann P; Krell PF; Borkhardt A; Dugas M; Hu J; Fischer U
Leuk Res; 2015 Sep; 39(9):990-1001. PubMed ID: 26189108
[TBL] [Abstract][Full Text] [Related]
31. Patterns of mutations in TP53 mutated AML.
Welch JS
Best Pract Res Clin Haematol; 2018 Dec; 31(4):379-383. PubMed ID: 30466751
[TBL] [Abstract][Full Text] [Related]
32. Therapy-related B-cell acute lymphoblastic leukemia in adults has unique genetic profile with frequent loss of TP53 and inferior outcome.
Barnea Slonim L; Gao J; Burkart M; Odetola OE; Kocherginsky M; Dinner SN; Lu X; Wehbe F; Jennings L; Altman JK; Mirza KM; Chen YH; Sukhanova M
Leukemia; 2021 Jul; 35(7):2097-2101. PubMed ID: 33087830
[No Abstract] [Full Text] [Related]
33. High prevalence and inferior long-term outcomes for TP53 mutations in therapy-related acute lymphoblastic leukemia.
Pourhassan H; Yang D; Afkhami M; Pillai R; Ball B; Al Malki M; Salhotra A; Ali H; Artz A; Curtin P; Armenian S; Stein A; Forman SJ; Marcucci G; Pullarkat V; Nakamura R; Aldoss I
Am J Hematol; 2022 May; 97(5):E171-E173. PubMed ID: 35132678
[No Abstract] [Full Text] [Related]
34. TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosis.
Stengel A; Schnittger S; Weissmann S; Kuznia S; Kern W; Kohlmann A; Haferlach T; Haferlach C
Blood; 2014 Jul; 124(2):251-8. PubMed ID: 24829203
[TBL] [Abstract][Full Text] [Related]
35. [The effect of TP53 mutations on the clinical outcomes of Ph-negative B-acute lymphoblastic leukemia following allogeneic hematopoietic stem cell transplantation].
Cao XY; Zhang Y; Liu DY; Zhang JP; Wei ZJ; Xiong M; Sun RJ; Lu Y; Zhou JR; Zhao YL; Ma W; Zhang W
Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):908-914. PubMed ID: 33333693
[No Abstract] [Full Text] [Related]
36. Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia.
Sebert M; Gachet S; Leblanc T; Rousseau A; Bluteau O; Kim R; Ben Abdelali R; Sicre de Fontbrune F; Maillard L; Fedronie C; Murigneux V; Bellenger L; Naouar N; Quentin S; Hernandez L; Vasquez N; Da Costa M; Prata PH; Larcher L; de Tersant M; Duchmann M; Raimbault A; Trimoreau F; Fenneteau O; Cuccuini W; Gachard N; Auger N; Tueur G; Blanluet M; Gazin C; Souyri M; Langa Vives F; Mendez-Bermudez A; Lapillonne H; Lengline E; Raffoux E; Fenaux P; Adès L; Forcade E; Jubert C; Domenech C; Strullu M; Bruno B; Buchbinder N; Thomas C; Petit A; Leverger G; Michel G; Cavazzana M; Gluckman E; Bertrand Y; Boissel N; Baruchel A; Dalle JH; Clappier E; Gilson E; Deriano L; Chevret S; Sigaux F; Socié G; Stoppa-Lyonnet D; de Thé H; Antoniewski C; Bluteau D; Peffault de Latour R; Soulier J
Cell Stem Cell; 2023 Feb; 30(2):153-170.e9. PubMed ID: 36736290
[TBL] [Abstract][Full Text] [Related]
37. Aneuploidy in children with relapsed B-cell precursor acute lymphoblastic leukaemia: clinical importance of detecting a hypodiploid origin of relapse.
Groeneveld-Krentz S; Schroeder MP; Reiter M; Pogodzinski MJ; Pimentel-Gutiérrez HJ; Vagkopoulou R; Hof J; Chen-Santel C; Nebral K; Bradtke J; Türkmen S; Baldus CD; Gattenlöhner S; Haas OA; von Stackelberg A; Karawajew L; Eckert C; Kirschner-Schwabe R
Br J Haematol; 2019 Apr; 185(2):266-283. PubMed ID: 30714092
[TBL] [Abstract][Full Text] [Related]
38. Alternative splicing of the tumor suppressor ASPP2 results in a stress-inducible, oncogenic isoform prevalent in acute leukemia.
Schittenhelm MM; Walter B; Tsintari V; Federmann B; Bajrami Saipi M; Akmut F; Illing B; Mau-Holzmann U; Fend F; Lopez CD; Kampa-Schittenhelm KM
EBioMedicine; 2019 Apr; 42():340-351. PubMed ID: 30952616
[TBL] [Abstract][Full Text] [Related]
39. Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma.
Martin-Guerrero I; Salaverria I; Burkhardt B; Chassagne-Clement C; Szczepanowski M; Bens S; Klapper W; Zimmermann M; Kabickova E; Bertrand Y; Reiter A; Siebert R; Oschlies I
Genes Chromosomes Cancer; 2019 Jun; 58(6):365-372. PubMed ID: 30578714
[TBL] [Abstract][Full Text] [Related]
40. TP53 in adult acute lymphoblastic leukemia.
Salmoiraghi S; Rambaldi A; Spinelli O
Leuk Lymphoma; 2018 Apr; 59(4):778-789. PubMed ID: 28679301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
